Modulation of the Mesenchymal Stem Cell Secretome Using Computer-Controlled Bioreactors: Impact on Neuronal Cell Proliferation, Survival and Differentiation
Authors
Affiliations
In recent years it has been shown that the therapeutic benefits of human mesenchymal stem/stromal cells (hMSCs) in the Central Nervous System (CNS) are mainly attributed to their secretome. The implementation of computer-controlled suspension bioreactors has shown to be a viable route for the expansion of these cells to large numbers. As hMSCs actively respond to their culture environment, there is the hypothesis that one can modulate its secretome through their use. Herein, we present data indicating that the use of computer-controlled suspension bioreactors enhanced the neuroregulatory profile of hMSCs secretome. Indeed, higher levels of in vitro neuronal differentiation and NOTCH1 expression in human neural progenitor cells (hNPCs) were observed when these cells were incubated with the secretome of dynamically cultured hMSCs. A similar trend was also observed in the hippocampal dentate gyrus (DG) of rat brains where, upon injection, an enhanced neuronal and astrocytic survival and differentiation, was observed. Proteomic analysis also revealed that the dynamic culturing of hMSCs increased the secretion of several neuroregulatory molecules and miRNAs present in hMSCs secretome. In summary, the appropriate use of dynamic culture conditions can represent an important asset for the development of future neuro-regenerative strategies involving the use of hMSCs secretome.
Standardization to Characterize the Complexity of Vessel Network Using the Aortic Ring Model.
Wolint P, Hofmann S, von Atzigen J, Boni R, Miescher I, Giovanoli P Int J Mol Sci. 2025; 26(1.
PMID: 39796147 PMC: 11719671. DOI: 10.3390/ijms26010291.
Da Silva K, Kumar P, Choonara Y Wound Repair Regen. 2025; 33(1):e13251.
PMID: 39780313 PMC: 11711308. DOI: 10.1111/wrr.13251.
Post-symptomatic administration of hMSCs exerts therapeutic effects in SCA2 mice.
Kim S, Sharma C, Hong J, Kim J, Nam Y, Kim M Stem Cell Res Ther. 2024; 15(1):411.
PMID: 39521966 PMC: 11550562. DOI: 10.1186/s13287-024-04020-8.
Engineering extracellular vesicles for ROS scavenging and tissue regeneration.
Abdal Dayem A, Yan E, Do M, Kim Y, Lee Y, Cho S Nano Converg. 2024; 11(1):24.
PMID: 38922501 PMC: 11208369. DOI: 10.1186/s40580-024-00430-9.
Bibliometric Analysis of Stem Cells in Ischemic Stroke (2001-2022): Trends, Hotspots and Prospects.
Yang T, Jiang N, Han H, Shui J, Hou M, Kumar G Int J Med Sci. 2024; 21(1):151-168.
PMID: 38164351 PMC: 10750336. DOI: 10.7150/ijms.86591.